Announce Date | 08/11/2025 |
EPS Normalized Actual | $-0.1 (Miss by $-0.01) |
EPS GAAP Actual | $-0.1 (Miss by $-0.01) |
Revenue Actual | $0.144054B |
Revenue Surprise | Beat by $144.054M |
Announce Date | 12/30/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.016667 |
EPS GAAP Estimate | $-0.016667 |
Revenue Estimate | $0.173866667B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | -0.63 | -0.54 | 0.144054B | -62.19% | -29.98M |
FQ1 2025 (Mar 2025) | -0.26 | -0.12667 | 0.181194B | -14.55% | 18.59M |
FQ4 2024 (Dec 2024) | -0.71 | -0.71 | 0.066276B | -242.81% | 66.28M |
FQ3 2024 (Sep 2024) | -0.0981 | -0.0981 | 0.209859B | 100% | 209.86M |
FQ2 2024 (Jun 2024) | 0.28 | 0.28 | 0.233642B | 100% | 233.64M |
FQ1 2024 (Mar 2024) | -0.19 | -0.19 | 0.207556B | 100% | 207.56M |
FQ4 2023 (Dec 2023) | -0.7 | -0.7 | 0.2272B | 100% | 227.2M |
FQ1 2014 (Mar 2014) | 1 | 1 | 0.347892B | 100% | 347.89M |
FQ4 Announce Date
12/30/2025 (Pre-Market)
Consensus EPS Estimates
-0.016667
Consensus Revenue Estimates
0.173866667B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.08 | -- | 0.08 | 0.08 | 1 |
FQ3 2027 (Sep 2027) | 0.01 | -- | 0.01 | 0.01 | 1 |
FQ2 2027 (Jun 2027) | -0.02 | -- | -0.02 | -0.02 | 1 |
FQ1 2027 (Mar 2027) | -0.04 | -- | -0.04 | -0.04 | 1 |
FQ4 2026 (Dec 2026) | 0.015 | -- | 0.015 | 0.015 | 1 |
FQ3 2026 (Sep 2026) | -0.005 | -- | -0.005 | -0.005 | 1 |
FQ2 2026 (Jun 2026) | -0.05 | -1160 | -0.05 | -0.05 | 1 |
FQ1 2026 (Mar 2026) | -0.065 | -300 | -0.065 | -0.065 | 1 |
FQ4 2025 (Dec 2025) | -0.016667 | -4159.91 | -0.016667 | -0.016667 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.21B | -- | 0.21B | 0.21B | 1 |
FQ3 2027 (Sep 2027) | 0.19B | -- | 0.19B | 0.19B | 1 |
FQ2 2027 (Jun 2027) | 0.18B | -- | 0.18B | 0.18B | 1 |
FQ1 2027 (Mar 2027) | 0.19B | -- | 0.19B | 0.19B | 1 |
FQ4 2026 (Dec 2026) | 0.2B | -- | 0.2B | 0.2B | 1 |
FQ3 2026 (Sep 2026) | 0.2B | -- | 0.2B | 0.2B | 1 |
FQ2 2026 (Jun 2026) | 0.18B | 21.62 | 0.18B | 0.18B | 1 |
FQ1 2026 (Mar 2026) | 0.17B | -7.31 | 0.17B | 0.17B | 1 |
FQ4 2025 (Dec 2025) | 0.17B | 61.88 | 0.17B | 0.17B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | -0.09 | -0.63 | -0.54 | 85.71% |
FQ1 2025 (Mar 2025) | -0.13333 | -0.26 | -0.12667 | 48.72% |
FQ4 2024 (Dec 2024) | -0.71 | -0.71 | 100% | |
FQ3 2024 (Sep 2024) | -0.0981 | -0.0981 | 100% | |
FQ2 2024 (Jun 2024) | 0.28 | 0.28 | 100% | |
FQ1 2024 (Mar 2024) | -0.19 | -0.19 | 100% | |
FQ4 2023 (Dec 2023) | -0.7 | -0.7 | 100% | |
FQ1 2014 (Mar 2014) | 1 | 1 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0.17B | $0.14B | $-29.98M | -20.81% |
FQ1 2025 (Mar 2025) | $0.16B | $0.18B | $18.59M | 10.26% |
FQ4 2024 (Dec 2024) | $0B | $0.07B | $66.28M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.21B | $209.86M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.23B | $233.64M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.21B | $207.56M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.23B | $227.2M | 100% |
FQ1 2014 (Mar 2014) | $0B | $0.35B | $347.89M | 100% |